Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
复制标题
DOI：
10.1093/ibd/izab337
复制
发表时间：
2022-07-01
影响因子：
4.9
通讯作者：
中科院分区：
文献类型：
--
作者：
炎症性肠病研究排除的冠状病毒监测流行病学（SECURE-IBD）数据库是一个国际IBD患者登记处，并确认了先前描述的COVID-19感染。7份报告中包含COVID-19感染前的疫苗接种数据，包括疫苗类型（辉瑞、Moderna、阿斯利康、Sputnik、Sinovac、国药、CanSino或“其他”，如杨森）、给药剂量和从末次给药至COVID-19感染的时间包括2020年12月12日至2021年10月1日之间的（< 30天，30-90天或≥ 90天）。如果疫苗类型、接种次数和/或COVID-19结局缺失，则排除患者。
MethodsThe Surveillance Epidemiology of Coronavirus Under Research Exclusion in Inflammatory Bowel Disease (SECURE-IBD) database is an international registry of patients with IBD and confirmed COVID-19 infection previously described. 7 Reports with data on vaccination prior to COVID-19 infection, including vaccine type (Pfizer, Moderna, AstraZeneca, Sputnik, Sinovac, Sinopharm, CanSino, or “other,” such as Janssen), doses administered, and time from last dose to COVID-19 infection (< 30 days, 30-90 days, or≥ 90 days) between December 12, 2020, and October 1, 2021, were included. Patients were excluded if vaccine type, number of doses, and/or COVID-19 outcomes were missing.
登录
查看更多内容
BNT162B2 mRNA COVID-19疫苗的安全性和功效。
DOI：
10.1056/nejmoa2034577
发表时间：
2020-12-31
期刊：
The New England journal of medicine
影响因子：
--
作者：
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者：
C4591001 Clinical Trial Group
影响因子：
29.4
作者：
Pozdnyakova V;Botwin GJ;Sobhani K;Prostko J;Braun J;Mcgovern DPB;Melmed GY;Appel K;Banty A;Feldman E;Ha C;Kumar R;Lee S;Rabizadeh S;Stein T;Syal G;Targan S;Vasiliauskas E;Ziring D;Debbas P;Hampton M;Mengesha E;Stewart JL;Frias EC;Cheng S;Ebinger J;Figueiredo JC;Boland B;Charabaty A;Chiorean M;Cohen E;Flynn A;Valentine J;Fudman D;Horizon A;Hou J;Hwang C;Lazarev M;Lum D;Fausel R;Reddy S;Mattar M;Metwally M;Ostrov A;Parekh N;Raffals L;Sheibani S;Siegel C;Wolf D;Younes Z
通讯作者：
Younes Z
DOI：
10.1056/nejmoa2035389
发表时间：
2021-02-04
期刊：
The New England journal of medicine
影响因子：
--
作者：
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者：
COVE Study Group
影响因子：
29.4
作者：
Ben-Tov A;Banon T;Chodick G;Kariv R;Assa A;Gazit S;Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force
通讯作者：
Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force
影响因子：
29.4
作者：
Khan N;Mahmud N
通讯作者：
Mahmud N